REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Innov Regulatory News (SEED)

Share Price Information for Seed Innov (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 2.10
Ask: 2.30
Change: 0.00 (0.00%)
Spread: 0.20 (9.524%)
Open: 2.20
High: 2.20
Low: 2.20
Prev. Close: 2.20
SEED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Continuation of Existing Share Buy-Back Programme

29 Feb 2024 09:00

RNS Number : 9404E
Seed Innovations Limited
29 February 2024

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

29 February 2024

SEED Innovations Limited

("SEED" or the "Company")

Continuation of Existing Share Buy-Back Programme

SEED Innovations Ltd, the AIM-quoted investment company with a portfolio of disruptive, high-growth life sciences and technology companies, is pleased to announce that it has extended its existing share repurchase programme (see RNS dated 19 September 2023) of Ordinary Shares (the "Programme") for up to a maximum of 21,500,000 shares and £850,000 for a further three months from the expiry of the original programme term to 30 May 2024. To date, 9,927,000 shares have been bought for c.£288,988.45.

Save for the extension of its term, the programme will continue to be run on the basis set out in the Company's announcement of 19 September 2023.

Any purchase of Ordinary Shares made in relation to this announcement will be carried out on the open market during the period commencing 1 March 2024 and ending not later than 30 May 2024. The Programme will be funded from the Company's existing cash resources.

Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other factors. Shard Capital Partners LLP is the Company's broker in relation to the Programme. The shares purchased by the Company will be held in treasury pending cancellation or re-issue.

The Programme will be conducted within the safe harbour parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019). Details of all purchases made pursuant to the Programme will be announced via RNS and published on the Company's website as required by the Market Abuse Regulations.

-Ends-

For further information on the Company please visit: www.seedinnovations.co or contact:

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

Notes

SEED Innovations Ltd

SEED Innovations Ltd is an AIM-quoted investment company providing shareholders with exposure to disruptive, high-growth, life sciences and technology companies. Its strategy is to identify early-stage opportunities that have an upcoming investment catalyst, and more mature investments that offer liquidity in the near term. To this end, it currently has eight active investments with a balance of liquid, pre-liquidity, and longer-term opportunities and is positioned to move quickly on other investment opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSEAPANAEXLEEA
Date   Source Headline
5th Dec 20227:00 amRNSInvestee Company Update: Clean Food Group Ltd
2nd Dec 202210:00 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Dec 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
11th Nov 202210:15 amRNSPortfolio Company Update: South West Brands
2nd Nov 20221:20 pmRNSInvestee Company Update: Little Green Pharma
4th Oct 202212:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Oct 20227:30 amRNSInvestee Company Update: Avextra
16th Sep 20229:03 amRNSEurox – Change of Name to Avextra
7th Sep 20224:00 pmRNSResult of AGM & Updated Investor Presentation
2nd Sep 20222:50 pmRNSPortfolio Valuation Update & Investor Presentation
9th Aug 20227:00 amRNSNotice of AGM & Investor Presentation
8th Aug 20227:00 amRNSFurther Investment in South West Brands Limited
1st Aug 20227:00 amRNSNew Investment: Clean Food Group Ltd
21st Jul 20227:00 amRNSFinal Results
12th Jul 202212:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
1st Jul 20225:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Jun 20223:05 pmRNSLoan to Portfolio Company, Leap Gaming
25th May 20222:08 pmRNSInvestee Company Update: Yooma Wellness Inc.
24th May 20227:00 amRNSInvestee Company Update: Leap Gaming
19th May 20227:00 amRNSInvestee Company Update - Little Green Pharma
18th May 20224:20 pmRNSInvestee Company Update: Yooma Wellness Inc.
4th May 20224:01 pmRNSInvestee Company Update: Yooma Wellness Inc.
3rd May 20227:00 amRNSInvestee Company Update - Little Green Pharma
19th Apr 20221:00 pmRNSInvestee Company Update: Little Green Pharma
6th Apr 20227:00 amRNSInvestee Company Update: Eurox Group
5th Apr 20227:00 amRNSFood Standard Agency’s Public List of CBD Products
31st Mar 202211:16 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Mar 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
18th Feb 20229:41 amRNSInvestee Company Update: Little Green Pharma Ltd
8th Feb 20221:51 pmRNSInvestee Company Update: Little Green Pharma Ltd
28th Jan 20227:00 amRNSSeed Investee Company Update: Little Green Pharma
17th Jan 20222:30 pmRNSInvestee Company Update: Yooma Wellness Inc.
13th Jan 20227:00 amRNSInvestee Company Update: Eurox Group
12th Jan 20229:15 amRNSInvestee Company Update: Eurox Group
7th Dec 20217:00 amRNSInterim Results
1st Dec 20217:00 amRNSInvestee Company Update: Yooma Wellness
29th Nov 20214:30 pmRNSChange of Registered Address and of Administrator
23rd Nov 20211:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
22nd Nov 20217:00 amRNSFurther Investment in Leap Gaming
2nd Nov 20217:00 amRNSInvestee Company Update: Eurox Group
20th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSInvestee Company Update: Yooma Wellness
4th Oct 20217:00 amRNSFurther Investment in South West Brands Limited
22nd Sep 20211:00 pmRNSResult of AGM & Updated Investor Presentation
20th Sep 202112:15 pmRNSPortfolio Company Update - Yooma Wellness
16th Sep 20217:00 amRNSInvestee Company Update: Factom Inc.
7th Sep 20217:00 amRNSInvestee Company Update: Little Green Pharma
1st Sep 20218:30 amRNSInvestee Company Update: Little Green Pharma Ltd
24th Aug 20217:00 amRNSNotice of AGM & Investor Presentation
20th Aug 20213:00 pmRNSInvestee Company Update: Yooma Wellness

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.